Description

IVERHUMAN CREAM 1% 30 GM

Indications

IVERHUMAN CREAM 1% is primarily indicated for the topical treatment of various dermatological conditions caused by susceptible strains of parasites and certain viral infections. This cream is commonly used to manage conditions such as scabies, lice infestations, and other skin infections that respond to ivermectin, the active ingredient. It may also be utilized in the treatment of some inflammatory skin conditions, where its antiparasitic properties can provide symptomatic relief.

Mechanism of Action

The active ingredient in IVERHUMAN CREAM, ivermectin, is a broad-spectrum antiparasitic agent. It functions by binding to specific ion channels in the nerve and muscle cells of parasites, leading to an increase in the permeability of the cell membranes to chloride ions. This hyperpolarization results in paralysis and death of the parasites. Additionally, ivermectin disrupts the function of the parasite’s glutamate-gated chloride channels, which are critical for their survival. The cream formulation allows for localized application, minimizing systemic absorption while effectively targeting the affected areas.

Pharmacological Properties

IVERHUMAN CREAM exhibits several pharmacological properties that contribute to its efficacy. Ivermectin has a high affinity for the glutamate-gated chloride channels in invertebrates, which is not present in mammals, thus providing a selective toxicity profile. The cream is designed for topical use, which reduces the risk of systemic side effects commonly associated with oral formulations. The pharmacokinetics of topical ivermectin suggest that it is minimally absorbed through the skin, allowing for concentrated action at the site of application while limiting systemic exposure.

Contraindications

IVERHUMAN CREAM is contraindicated in individuals with a known hypersensitivity to ivermectin or any of the excipients in the formulation. It should not be used on open wounds, mucous membranes, or in the eyes. Caution is advised when considering use in patients with a history of neurological disorders, as ivermectin can potentially exacerbate these conditions. Pregnant and breastfeeding women should consult a healthcare provider before using this medication.

Side Effects

While IVERHUMAN CREAM is generally well tolerated, some patients may experience side effects. Commonly reported adverse reactions include local skin irritation, redness, itching, and burning sensations at the site of application. In rare cases, systemic side effects such as dizziness, headache, or gastrointestinal disturbances may occur, particularly if the cream is used excessively or improperly. If any severe allergic reactions or signs of systemic toxicity occur, immediate medical attention should be sought.

Dosage and Administration

The recommended dosage of IVERHUMAN CREAM is to apply a thin layer to the affected area of the skin once daily. The cream should be gently massaged into the skin until fully absorbed. Treatment duration may vary depending on the specific condition being treated, but it is generally recommended to continue use for 7 to 14 days, or as directed by a healthcare professional. It is important to wash hands thoroughly after application to avoid unintentional contact with other areas of the body or with other individuals.

Interactions

IVERHUMAN CREAM is primarily a topical formulation with minimal systemic absorption, which reduces the likelihood of significant drug interactions. However, caution should be exercised when used concurrently with other topical medications, as they may alter the efficacy of ivermectin or increase the risk of local irritation. Patients should inform their healthcare provider of all medications, both topical and systemic, that they are currently using to ensure safe and effective treatment.

Precautions

Clinical Studies

Clinical studies evaluating the efficacy of ivermectin in various dermatological conditions have demonstrated its effectiveness in treating scabies and lice infestations. Research published in peer-reviewed journals has shown that topical ivermectin significantly reduces parasite counts and alleviates associated symptoms. In a randomized controlled trial, patients treated with topical ivermectin exhibited a higher cure rate compared to those receiving placebo or alternative treatments. The safety profile of topical ivermectin has also been established, with most side effects being mild and transient.

Conclusion

IVERHUMAN CREAM 1% is a valuable therapeutic option for the topical treatment of certain dermatological conditions caused by parasites. Its mechanism of action, pharmacological properties, and clinical efficacy make it a preferred choice for managing scabies and lice infestations. While generally well tolerated, patients should be aware of potential side effects and contraindications. Proper use and adherence to dosing recommendations are essential for achieving optimal therapeutic outcomes. Consultation with a healthcare provider is recommended for personalized treatment guidance.

Important

It is crucial to use IVERHUMAN CREAM responsibly and only as directed by a healthcare professional. Misuse or overuse can lead to adverse effects and reduced efficacy. Always consult a healthcare provider for personalized advice and treatment options.